Searchable abstracts of presentations at key conferences in endocrinology

ea0012p43 | Diabetes, metabolism and cardiovascular | SFE2006

What is the relationship between testosterone and fat mass in young male cancer survivors and healthy controls?

Greenfield DM , Walters SJ , Eastell R , Coleman RE , Hancock BW , Snowden J , Ross RJ

Background and AimIt is known that the variability of testosterone concentrations is predictive of both truncal and peripheral obesity in healthy men. The aim of this study was to establish the nature of the relationship between testosterone and fat mass in young male cancer survivors compared with healthy controls.Subjects176 male cancer survivors (mean age 37.3 years SD 5.8) who previously received gonadoto...

ea0011p710 | Reproduction | ECE2006

Endocrine evaluation of a large cohort of male cancer survivors compared with healthy controls

Greenfield DM , Coleman RE , Hancock BW , Davies HA , Snowden J , Ross RJ

Background: Men who receive gonadotoxic treatment for cancer may be at risk of hypogonadism. The extent of this risk is unknown. Severe hypogonadism is associated with fatigue, sexual dysfunction, reduced muscle mass and obesity. Diagnosing mild or moderate hypogonadism is difficult and requires evaluation.Aim: The aim of this study was to identify hypogonadism in young male survivors of cancer.Subjects and Methods: The study was a...